11:09 AM EDT, 07/02/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking lower late Wednesday, declining 0.38% to 1,481.07 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and internet advertising firm Criteo ( CRTO ) , which rose 4.2% and 2.4%, respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and oil and gas company TotalEnergies (TTE), which were up 1.7% and 1.2%, respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) and biopharmaceutical firm DBV Technologies ( DBVT ) , which fell 3.6% and 3.2%, respectively. They were followed by consumer goods company Unilever ( UL ) and semiconductor company Sequans Communications ( SQNS ) , which were down 1.3% and 1%, respectively.

From the UK and Ireland, the gainers were led by biotech company Autolus Therapeutics ( AUTL ) and biopharmaceutical firm Bicycle Therapeutics ( BCYC ) , which increased 4.2% and 3.6%, respectively. Biopharmaceutical firms Mereo BioPharma Group ( MREO ) and Verona Pharma ( VRNA ) rose 3.5% and 2.8%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and financial services company Lloyds Banking Group ( LYG ) , which lost 9.1% and 5.1% respectively. They were followed by utilities company National Grid ( NGG ) and biotech company Trinity Biotech ( TRIB ) , which dropped 4.4% and 3% respectively.